Bodenrader Mark's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Dec 21, 2023
- Accession no.
- 0000950170-23-072381
- Filed
- Dec 21, 2023
- Trade date
- Dec 19-20, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $326.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bodenrader MarkCIK 0001830371 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | Common Stock | MOption exerciseAcquired | +14,199 | – | – | 20,528 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseAcquired | +5,085 | – | – | 25,613 | Direct | |
| Dec 20, 2023 | Common Stock | SSaleDisposed | −7,889 | $41.42 | −$326,762.38 | 17,724 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | Common Stock | MOption exerciseDisposed | −14,199 | $0.00 | $0 | 0 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseDisposed | −5,085 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.